Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saisantosh Ponna
Institution:
Indiana University School of Medicine
Observed institutions:
University of Notre Dame,
Indiana University School of Medicine
ORCID:
0000-0001-6538-6088
Observed ORCID:
0000-0001-6538-6088
OpenAlex ID:
A5039300625
Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
2023
·
Md Sazzad Hassan
, Niranjan Awasthi
, et al.
·
Biomedicines
·
32
PDF
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma
2024
·
Md Sazzad Hassan
, Chloe Johnson
, et al.
·
Cancers
·
10
PDF
Abstract 555: Role of TRIM31 in the pathogenesis of esophageal adenocarcinoma
2024
·
Md Sazzad Hassan
, Jesse Mast
, et al.
·
Cancer Research
·
1
Clinical Correlates of Opioid Use Disorder Symptom Scores: Retrospective Analysis of Patient-Reported Treatment History
2026
·
Saisantosh Ponna
, Michael Bushey
·
Proceedings of IMPRS
PDF
Abstract 3960: Therapeutic targeting of HIF-1 alpha induced CD73 expression in experimental esophageal adenocarcinoma
2023
·
Md Sazzad Hassan
, Aktar Ali
, et al.
·
Cancer Research
Abstract 2624: Methadone hydrochloride blocks epinephrine-induced proliferation and enhances apoptotic effects of nab-paclitaxel in esophageal adenocarcinoma
2022
·
Nicholas Cwidak
, Sazzad Hassan
, et al.
·
Cancer Research
Abstract 1066: BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor is cytotoxic to esophageal adenocarcinoma cells and enhances nab-paclitaxel response in experimental esophageal adenocarcinoma
2022
·
Md Sazzad Hassan
, Nicholas Cwidak
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
43
H-index:
2
I10-index:
2
Year
Topic
Type